Schering-Plough
SGP
#532
Rank
โ‚ฌ39.96 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: โ‚ฌ16.00 Billion

In 2008 the company made a revenue of โ‚ฌ16.00 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008โ‚ฌ16.00 B
2006โ‚ฌ9.16 B11.42%
2005โ‚ฌ8.22 B14.94%
2004โ‚ฌ7.15 B-0.74%
2003โ‚ฌ7.21 B-18.13%
2002โ‚ฌ8.80 B3.86%
2001โ‚ฌ8.48 B-0.13%
2000โ‚ฌ8.49 B6.96%
1999โ‚ฌ7.93 B13.61%
1998โ‚ฌ6.98 B19.16%
1997โ‚ฌ5.86 B19.84%
1996โ‚ฌ4.89 B